SCHEMBL796033

SCHEMBL796033

Fc1c(Cl)cc(Cl)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TSHR P16473 5/20 0.38
HSD17B10 Q99714 3/20 0.38
CYP3A4 P08684 2/20 0.38
RECQL P46063 2/20 0.38
ERN1 O75460 1/20 0.34
AHR P35869 4/20 0.33
HPGD P15428 2/20 0.33
TP53 P04637 1/20 0.32
EGFR P00533 2/20 0.32
KDM1A O60341 2/20 0.31
KDM1B Q8NB78 2/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
PDK2 Q15119 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
SLC22A2 O15244 1/20 0.30
SLC22A1 O15245 1/20 0.30
NR1I2 O75469 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21594657 0.86 TSHR (0.41) ALDH1A1TSHRHSD17B10CYP3A4RECQL
SCHEMBL3682577 0.80 ALDH1A1 (0.53) ALDH1A1TSHRHSD17B10CYP3A4RECQL
SCHEMBL29429741 0.79 TSHR (0.35) TSHRERN1HPGDEGFRKDM1A
SCHEMBL18302718 0.79 GAA (0.32) AHRKDM1AKDM1B
SCHEMBL22165559 0.79 TSHR (0.35) TSHRERN1HPGDEGFRKDM1A
SCHEMBL14247166 0.79 NMT1 (0.38) TSHRCYP3A4AHRKDM1AKDM1B
SCHEMBL30543313 0.79 GAA (0.32) AHRKDM1AKDM1B
SCHEMBL8529116 0.76 KDM1A (0.35) AHRKDM1AKDM1B
SCHEMBL22119947 0.75 TSHR (0.41) ALDH1A1TSHRHSD17B10CYP3A4RECQL
SCHEMBL22289546 0.75 ERN1 (0.32) TSHRERN1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102066002-A In situ olefin polymerization catalyst system PROMERUS LLC 2011-05-18 CN claimed
US-20250340548-A1 KRAS G12C INHIBITORS FRONTIER MEDICINES CORP (US) 2025-11-06 US disclosed
US-12291539-B2 KRAS G12C inhibitors FRONTIER MEDICINES CORPORATION (US) 2025-05-06 US disclosed
US-20250019387-A1 KRAS G12C INHIBITORS FRONTIER MEDICINES CORPORATION 2025-01-16 US disclosed
EP-4426695-A1 KRAS G12C INHIBITORS Frontier Medicines Corporation (US) 2024-09-11 EP disclosed
WO-2023081840-A1 KRAS G12C INHIBITORS FRONTIER MEDICINES CORPORATION (US) 2023-05-11 WO disclosed
US-9375000-B2 Pesticidal arylpyrrolidines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-06-28 US disclosed
US-9375000-B2 Pesticidal arylpyrrolidines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-06-28 US disclosed
US-9375000-B2 Pesticidal arylpyrrolidines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-06-28 US disclosed
US-9206122-B2 Pesticidal arylpyrrolidines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-12-08 US disclosed
US-20150025253-A1 PESTICIDAL ARYLPYRROLIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-01-22 US disclosed
EP-2825532-A1 PESTICIDAL ARYLPYRROLIDINES Bayer Intellectual Property GmbH (DE) 2015-01-21 EP disclosed
US-20140046069-A1 PESTICIDAL ARYLPYRROLIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-02-13 US disclosed
US-20140046069-A1 PESTICIDAL ARYLPYRROLIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-02-13 US disclosed
US-20140046069-A1 PESTICIDAL ARYLPYRROLIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-02-13 US disclosed
WO-2013135724-A1 PESTICIDAL ARYLPYRROLIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-19 WO disclosed
EP-2616437-A1 PESTICIDAL ARYLPYRROLIDINES Bayer Intellectual Property GmbH (DE) 2013-07-24 EP disclosed
WO-2012035011-A1 PESTICIDAL ARYLPYRROLIDINES BAYER CROPSCIENCE AG (DE) 2012-03-22 WO disclosed
WO-2012035011-A1 PESTICIDAL ARYLPYRROLIDINES BAYER CROPSCIENCE AG (DE) 2012-03-22 WO disclosed
CN-102066002-A In situ olefin polymerization catalyst system PROMERUS LLC 2011-05-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291539-B2 KRAS G12C inhibitors KRAS, NRAS, HRAS ALDH1A1 3319/4885TSHR 3724/4885HSD17B10 4044/4885
US-20250340548-A1 KRAS G12C INHIBITORS KRAS, NRAS, HRAS ALDH1A1 3319/4885TSHR 3724/4885HSD17B10 4044/4885
US-20140046069-A1 PESTICIDAL ARYLPYRROLIDINES DDT, ACHE, CAT ALDH1A1 322/4885TSHR 356/4885HSD17B10 4038/4885
US-20150025253-A1 PESTICIDAL ARYLPYRROLIDINES DDT, ACHE, NPEPPS ALDH1A1 165/4885TSHR 151/4885HSD17B10 3407/4885
US-20250019387-A1 KRAS G12C INHIBITORS KRAS, NRAS, HRAS ALDH1A1 3319/4885TSHR 3724/4885HSD17B10 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.